+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cytokinetics Inc (CYTK) - Financial and Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 58 Pages
  • July 2025
  • GlobalData
  • ID: 4267292
Cytokinetics Inc (CYTK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the analyst to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Cytokinetics Inc (Cytokinetics) is a biopharmaceutical company with a focus on the discovery, development, and commercialization of muscle activators and muscle inhibitors as potential treatments for debilitating diseases wherein muscle performance is affected. The company develops small molecule drug candidates which is designed to affect muscle function and contractility. Cytokinetics is developing aficamten, a next-generation cardiac myosin inhibitor, to treat hypertrophic cardiomyopathy (HCM). It is also developing Muscle biology-directed research, neuromuscular, cardiac myosin activator and additional skeletal muscle activators. Cytokinetics is headquartered in South San Francisco, California, the US.

Cytokinetics Inc Key Recent Developments

  • May 15, 2025: Cytokinetics To Host Symposium on Contemporary Landscapes in Muscle Biology
  • May 06, 2025: Cytokinetics Reports First Quarter 2025 Financial Results and Provides Business Update
  • Feb 27, 2025: Cytokinetics Reports Fourth Quarter 2024 Financial Results and Provides Business Update
  • Feb 11, 2025: Cytokinetics Names Robert E. Landry to Board of Directors

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • Cytokinetics Inc - Key Facts
  • Cytokinetics Inc - Key Employees
  • Cytokinetics Inc - Key Employee Biographies
  • Cytokinetics Inc - Major Products and Services
  • Cytokinetics Inc - History
  • Cytokinetics Inc - Company Statement
  • Cytokinetics Inc - Locations And Subsidiaries
  • Head Office
Section 2 - Company Analysis
  • Company Overview
  • Cytokinetics Inc - Business Description
  • Other Break-up: Milestone
  • Performance
  • Other Break-up: Realization of Revenue Participation Right Purchase Agreement
  • Performance
  • Other Break-up: Research and Development
  • Performance
  • R&D Overview
  • Cytokinetics Inc - Corporate Strategy
  • Cytokinetics Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Cytokinetics Inc - Strengths
  • Cytokinetics Inc - Weaknesses
  • Cytokinetics Inc - Opportunities
  • Cytokinetics Inc - Threats
  • Cytokinetics Inc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Cytokinetics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2019 to YTD 2025
  • Cytokinetics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2019 to YTD 2025
  • Cytokinetics Inc, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • May 15, 2025: Cytokinetics To Host Symposium on Contemporary Landscapes in Muscle Biology
  • May 06, 2025: Cytokinetics Reports First Quarter 2025 Financial Results and Provides Business Update
  • Feb 27, 2025: Cytokinetics Reports Fourth Quarter 2024 Financial Results and Provides Business Update
  • Feb 11, 2025: Cytokinetics Names Robert E. Landry to Board of Directors
  • Jan 30, 2025: Cytokinetics Announces Recipients of Its Seventh Annual Communications Grant Program
  • Jan 13, 2025: Cytokinetics Announces 2025 Corporate Milestones and Vision 2030
  • Dec 16, 2024: Cytokinetics Announces Appointment of Certain Officers
  • Nov 06, 2024: Cytokinetics Reports Third Quarter 2024 Financial Results
  • Sep 24, 2024: Cytokinetics Announces Call for Proposals for Its Seventh Annual Communications Grant Program
  • Aug 08, 2024: Cytokinetics Reports Second Quarter 2024 Financial Results
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Analyst
  • Contact the Publisher
  • Disclaimer
List of Tables
  • Cytokinetics Inc, Key Facts
  • Cytokinetics Inc, Key Employees
  • Cytokinetics Inc, Key Employee Biographies
  • Cytokinetics Inc, Major Products and Services
  • Cytokinetics Inc, History
  • Cytokinetics Inc, Key Competitors
  • Cytokinetics Inc, Ratios based on current share price
  • Cytokinetics Inc, Annual Ratios
  • Cytokinetics Inc, Interim Ratios
  • Cytokinetics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2019 to YTD 2025
  • Cytokinetics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2019 to YTD 2025
  • Cytokinetics Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Cytokinetics Inc, Performance Chart (2020 - 2024)
  • Cytokinetics Inc, Ratio Charts
  • Cytokinetics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2019 to YTD 2025
  • Cytokinetics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2019 to YTD 2025

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Stealth BioTherapeutics Inc.
  • MediciNova Inc
  • Revalesio Corp
  • Regeneron Pharmaceuticals Inc
  • Mitsubishi Tanabe Pharma Corp
  • AB Science SA
  • Orphazyme A/S
  • BrainStorm Cell Therapeutics Inc
  • PTC Therapeutics Inc
  • Amylyx Pharmaceuticals Inc
  • Alexion Pharmaceuticals Inc